Skip to main content
. 2008 May 19;28(14):4507–4519. doi: 10.1128/MCB.00308-08

TABLE 3.

Correlation between oligonucleotide length and TLR3 inhibitory activity

Length (nt) Sequence NF-κβ activitya (%) (SE)
19 CCTTACCCATAATCAACTC 105 (8)
24 TTGGCCCTTACCCATAATCAACTC 86 (15)
25 GTCGACAAGGGATTGAACCTCGTTC 103 (8)
29 CAGTGTTGGCCCTTACCCATAATCAACTC 58 (6)
30 TACGTACTTAGATATGTCTTCAAACCATAC 67 (3)
34 CATAACAGTGTTGGCCCTTACCCATAATCAACTC 44 (3)
36 GGCTTCACTTTCATAGACTGCAACGGTGCCTGAAAG 38 (1)
39 ACAAACATAACAGTGTTGGCCCTTACCCATAATCAACTC 38 (1)
40 GCTCTAGATTAAGATTTACCGATGTCGCTCACTAAGGACC 32 (1)
41 AGTTCTAGACTACGTGACGACCTCCAGGTCAGCCGACATGC 35 (5)
43 ACAACTTAAATGTGGTTGGTGCCGATTCCTTTGCTTGGCTTCC 33 (1)
45 GAAGAACTGGATATCTTTGCCGCTTCATCTTTAAAAAAATTAGAG 47 (4)
53 AGTGCTAGCAGTCATCCAACAGAATCATGTCGATGTCCACTACATGGACAGGC 38 (4)
54 CAGTGCTAGCAGTCATCCAACAGAATCATGAATGGAATATTTGCTATTGAGAAG 36 (2)
56 AGTGCTAGCAGTCATCCAACAGAATCATGGCCCCCATCACGTACTCCACCTATGGC 22 (4)
57 AGTGCTAGCAGTCATCCAACAGAATCATGAGCACCTGGGTGCTGGTAGGCGGAGTCC 29 (2)
58 AGTGCTAGCAGTCATCCAACAGAATCATGGCCTCACACCTCCCTTACATCGAAGACGG 27 (4)
60 CTCGAGCAGAGGTCTCACACAGAGACAAGCGCATCAGTCAACAGAGATCCCTTGCGCTTC 35 (1)
75 GTCGACCACGGTTCTGCTACTTGTTCTTTGTTTTTCACCAACAAAATGGTATGGTTTGAAGACATATCTAAGTAC 30 (7)
a

TLR3 activity obtained with poly(I-C) as the ligand was set at 100%.

HHS Vulnerability Disclosure